[1]
G. F. . . da Silva, M. I. . de Toledo, A. D. R. . Lima, R. E. M. . de Oliveira, and M. M. M. de A. . Meiners, “ANTI-FLU DRUGS IN BRAZIL: COMMERCIALIZATION BEFORE AND DURING THE COVID-19 PANDEMIC”, ARE, vol. 6, no. 4, pp. 17986–18001, Dec. 2024, doi: 10.56238/arev6n4-406.